Perhaps reality is finally setting in?
There are no mundipharma sales other than shipment of a few devices sent to Singapore because Australia, like numerous other countries rleis on the CE Mark as its prerequisite benchmark, just like the EU. No CE Mark, no exports to Australia. I posed a very simple question in post 216997, but no guesses so far. The estimated figure is staggering and knowledge of it would ruin the weekend.
I suspect there was never a formal deal done with B. Braun, talks, yes, deal, no, because a deal would have produced sales! Same with the VA, a deal would have produced sales. The train remains in the barn.
Most amazing disruptive technology in pain management ever, and the train to success for shareholders, all shareholders, is stuck in the barn. Needs effective management fixing the share structure, eradicating the toxicity of the Whelan name, caused by the former CEO and making deals. Deals mean sales and making deals is virtually impossible with red flags popping up.
Google BioElectronics Corp. red flags, something retailers and large players in the pharma space do every day, as part of their DD, and just read the lead-ins, don't even open a link. First 5 results lead with: - "Huge Scam; Bioelectronics et al SEC.gov.; Fails to move up; Drops after FDA meeting; and Crashes once more.".
I would rather see leads-ins on google like: - "BIEL cleans house; BIEL courageously rectifies share structure issues; BIEL majority owner steps aside to allow success; BIEL in talks with . . . . . ; BIEL now the retail and OEM leader in the pain space; and, BIEL stock price soars with new developments". The difference in the two scenarios is about two weeks of dynamic, effective leadership and management.
